Percutaneous Coronary Revascularization
3 clinical trials · Condition
◉ Watch Percutaneous Coronary Revascularization
| Record | Firm | Date |
|---|---|---|
| Evaluation in STEMI Patients Using FDY-5301 (NCT04837001) | Faraday Pharmaceuticals, Inc. | 2022-05-02 |
Track Percutaneous Coronary Revascularization automatically
Every clearance here is in the API, with alerts when new ones post.